A potential therapy for Glucose transporter 1 deficiency syndrome (Glut1 DS) has produced negative results in phase 3 of its clinical trial.
Glut 1 deficiency syndrome trial announces negative results Read More »
Study finds anti-viral drug leads to decrease in frataxin levels and may be a potential future candidate for treating Friedreich’s ataxia (FA).
HIV treatment identified as potential future therapy for FA Read More »
This week results were published showing the effects of an AAV (adeno-associated virus) gene therapy in a new mouse model of Friedreich’s ataxia (FA).
Hope for gene therapy for Friedreich’s ataxia Read More »
Experiments performed in mice and in cells taken from Friedreich’s ataxia (FA) patients reveal a protein called ‘GRP75’ might be an effective future treatment approach.
Increasing levels of a protein in FA may be potential future therapy Read More »
Ataxia UK, GoFAR, FARA US and FARA Australia are pleased to announce the date of 3rd International Ataxia Research Conference.
International Ataxia Research Conference (IARC) 2019 – Save the date! Read More »
We interview PhD student Wayne Yau about life as an ataxia researcher working on an Ataxia UK funded investigation on the role of genetic DNA repair mechanisms in a range of ataxias.
Interview with PhD student and ataxia researcher Wayne Yau Read More »
Results from a phase 2 clinical trial suggest that a new therapy may improve neurological function and prevent disease progression relative to the natural course of Friedreich’s ataxia (FA).
Omaveloxolone has recently been given an Orphan drug designation for Friedreich’s ataxia the European Medicines Agency.
New EU Orphan drug designation for Freidreich’s ataxia Read More »
A new placebo-controlled trail in humans, testing a novel therapy, Tak-831 for Friedreich’s ataxia, has begun in America.
Results of a study evaluating TAK-831 in adults with Friedreich’s ataxia (FA) Read More »
The results of the patient communications survey conducted at the 2018 Ataxia UK conference were presented in London by Ataxia UK partners Costello Medical.
Results presented from patient communications survey Read More »
Results from MOXIe study reveal potential therapy for Friedreich’s ataxia, omaveloxolone, is well tolerated.
Results published from part 1 of Friedreich’s ataxia drug trial Read More »
International Ataxia Research Conference (IARC) 2019 – Save the date! Ataxia UK, GoFAR, FARA US and FARA Australia are pleased to announce the next International Ataxia Research Conference to be
Research News – October 2018 Read More »
Second trial investigating troriluzole in spinocerebellar ataxia announced by Biohaven pharmaceuticals to commence at the end of January.
SCA drug trial to begin in America Read More »
The latest findings from a trial testing a potential new gene therapy for Friedreich’s ataxia have been announced.
Data released from preclinical study into gene therapy for Friedreich’s ataxia Read More »
Interview with PhD student and ataxia researcher Wayne Yau Ataxia UK is funding a project alongside the Spanish organisations R+SCAs (Plataforma de Apoyo a la Investigación de las Ataxias Espinocerebelosas)
Interview with PhD student and ataxia researcher Wayne Yau Read More »
Catch up on the latest research news!
Research News – May and June 2018 Read More »
IntraBio, a U.K. based biopharmaceutical company, has received an Orphan Drug Designation from the US Food and Drug Administration (FDA) for its lead compound (IB1000) for the treatment of spinocerebellar
FDA Orphan Drug Designation for Spinocerebellar Read More »
Ataxia UK was represented by research officer Dr Julie Vallortigara at the World Orphan Drug Congress in Washington DC. She shares her experience about this event.
World Orphan Drug Congress 2018 – Washington DC Read More »
Catch up on the Autumn’s latest research news.
Research News – October and November 2017 Read More »
A speech therapy clinical trial aiming to begin in February are urgently seeking people with FA to take part.
Ataxia UK is working for the first time with the Spanish ataxia patient group R+SCAs (PLATAFORMA DE APOYO A LA INVESTIGACIÓN DE LAS ATAXIAS ESPINOCEREBELOSAS) in funding a research project
New partnership between Ataxia UK and the Spanish organisations R+SCAs and ACAH Read More »
Read up on the latest research news!
Latest Research News – May and June 2017 Read More »
Catch up on the Autumn’s latest research news.
Research News – August and September 2017 Read More »
Ataxia UK’s involvement with AMRC’s report on the impact of medical charity-funded research.
AMRC Impact Report: Ataxia UK Case Study Featured Read More »
Read up on the latest research news!
Latest Research News – March and April 2017 Read More »
Read up on the latest research news!
Latest Research News – January and February 2017 Read More »
Read up on the latest research news!
Latest Research News – December 2016 Read More »
